You have 9 free searches left this month | for more free features.

Condition

Breast Cancer (1)

Non Small Cell Lung Cancer (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Syndax Pharmaceuticals (2)

Collaborator

Intervention

sndx-275 (2)

erlotinib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

sndx-275

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Breast Cancer Trial in Indianapolis (SNDX-275)

Terminated

Breast Cancer

SNDX-275

Indianapolis, Indiana

Monet Bowling, MD

Jun 1, 2022

Non Small Cell Lung Cancer Trial in United States (SNDX-275, erlotinib)

Completed

Non Small Cell Lung Cancer

SNDX-275
erlotinib

Duarte, California
+11 more

Apr 25, 2022